5.26
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Low
1.60
High
10.9718
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 5.26 | 04:00:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.26 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.10 | 5.14 | 0.04 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 3 | 91,672 | 1.60 - 10.9718 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:05:08 | 3 | $ 5.14 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 81.37M | 15.47M | 8.93M | $ 262.94k | $ - | -0.19 | -29.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 23.70% |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.80 | 5.85 | 4.75 | 5.18 | 103,139 | -0.54 | -9.31% |
| 1 Month | 5.22 | 5.90 | 4.75 | 5.41 | 88,142 | 0.04 | 0.77% |
| 3 Months | 5.40 | 7.17 | 4.21 | 5.68 | 113,977 | -0.14 | -2.59% |
| 6 Months | 3.12 | 10.9718 | 2.85 | 5.61 | 278,025 | 2.14 | 68.59% |
| 1 Year | 1.74 | 10.9718 | 1.60 | 3.62 | 1,127,906 | 3.52 | 202.3% |
| 3 Years | 2.4686 | 10.9718 | 0.50 | 3.44 | 498,139 | 2.79 | 113.08% |
| 5 Years | 2.5263 | 10.9718 | 0.50 | 3.59 | 380,461 | 2.73 | 108.21% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
